Estrogen regulates energy metabolic pathway and upstream adenosine 5'-monophosphate-activated protein kinase and phosphatase enzyme expression in dorsal vagal complex metabolosensory neurons during glucostasis and hypoglycemia.
Estrogen regulates energy metabolic pathway and upstream adenosine 5'-monophosphate-activated protein kinase and phosphatase enzyme expression in dorsal vagal complex metabolosensory neurons during glucostasis and hypoglycemia.
复制标题
DOI:
10.1002/jnr.23481
复制
发表时间:
2015-02
影响因子:
4.2
通讯作者:
Briski, Karen P.
中科院分区:
文献类型:
--
作者:
Tamrakar, Pratistha;Ibrahim, Baher A.;Gujar, Amit D.;Briski, Karen P.
关键词:
The ability of estrogen to shield the brain from the bio-energetic insult, hypoglycemia, is unclear. Estradiol prevents hypoglycemic activation of the energy deficit sensor, adenosine 5′-monophosphate-activated protein kinase (AMPK), in hindbrain metabolo-sensory A2 noradrenergic neurons. Here, we investigated the hypothesis that estrogen regulates A2 AMPK through control of fuel metabolism and/or upstream protein kinase/phosphatase enzyme expression. A2 cells were harvested by laser-microdissection after insulin (INS) or vehicle (V) injection of estradiol (E)- or oil (O)-implanted ovariectomized female rats. Cell lysates were evaluated by immunoblot for glycolytic, tricarboxylic acid cycle (TCA), respiratory chain, and acetyl CoA-malonyl CoA pathway enzymes. A2 phosphofructokinase (PFKL), isocitrate dehydrogenase, and pyruvate dehydrogenase and ATP synthase subunit profiles were elevated in E/V versus O/V; hypoglycemia augmented PFKL and alpha-ketoglutarate dehydrogenase expression in E only. Hypoglycemia increased A2 Ca++/calmodulin-dependent protein kinase-beta in O, while reducing PP2A in both groups. A2 phosphoAMPK levels were equivalent in O/V versus E/V, but elevated during hypoglycemia in O only. These results implicate estradiol in compensatory up-regulation of substrate catabolism and corresponding maintenance of energy stability of A2 metabolo-sensory neurons during hypoglycemia, outcomes that support the potential viability of molecular substrates for hormone action as targets for therapies alleviating hypoglycemic brain injury.
登录
查看更多内容
影响因子:
4.1
作者:
Briski, KP;Marshall, ES;Sylvester, PW
通讯作者:
Sylvester, PW
影响因子:
3.2
作者:
Krebs, B;Kohlmannsperger, V;Kretzschmar, HA
通讯作者:
Kretzschmar, HA
影响因子:
5.3
作者:
Nilsen, Jon;Irwin, Ronald W.;Brinton, Roberta Diaz
通讯作者:
Brinton, Roberta Diaz
DOI:
10.1152/ajpregu.00177.2004
发表时间:
2005-12-01
影响因子:
2.8
作者:
Patil, GD;Briski, KP
通讯作者:
Briski, KP
影响因子:
3.3
作者:
Briski, K. P.;Cherian, A. K.;Vavaiya, K. V.
通讯作者:
Vavaiya, K. V.